Indobufen Dual Antiplatelet Therapy (DAPT) Versus Aspirin Dual Antiplatelet Therapy (DAPT) After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta‐Analysis
Indobufen-based (DAPT) had a lower incidence of bleeding than aspirin-based (DAPT), with no difference between the two groups for MACCE, myocardial infarction, ischemic stroke, cardiovascular death, repeat vascularization, or stent thrombosis.
Authors
- M. Mamas
- Tugba Saka
- Osama Barakat
- M. Elhadi
- Tasneem Mustafa Yousif
- Abdelrahman Saeed
- Omar Saeed
- Aeshah Mohammed Adim
- Abdulaziz Bawjeh
Institutions
- University of Aleppo (SY)
- Sebha University (LY)
- Al-Azhar University (EG)
- Korea University (KR)
- Hadhramout University (YE)
- Istinye University (TR)
- Keele University (GB)
- University of Gezira (SD)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1002/ccd.70463
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00